Preconceptional immunomodulation partially corrects pregnancy associated abnormalities induced by endometriosis in a mice model, with a normalization of transcriptional alteration observed in the developing fetal maternal interface at the single cell level.

Using a surgically induced mouse model, this study demonstrates that preconceptional immunomodulation partially reverses endometriosis-induced pregnancy complications and normalizes specific transcriptional alterations in the fetal-maternal interface, suggesting that targeting the immune system could improve pregnancy outcomes for women with endometriosis.

The Gist

The Big Picture: A Garden in a Storm

Imagine a woman's uterus as a garden designed to grow a baby (a seed). For the garden to be successful, the soil needs to be rich, the fences (immune system) need to be friendly, and the weather needs to be calm.

Endometriosis is like a weed that has taken over parts of the garden. It's not just a weed; it's a stubborn, inflammatory weed that changes the soil chemistry and makes the garden hostile. Women with this condition often struggle to get pregnant, and if they do, the "seed" is more likely to die or the garden might collapse (miscarriage).

This study asked two big questions:

1. Why does this weed ruin the pregnancy?
2. Can we train the garden's security guards (the immune system) to ignore the weed and protect the baby instead?

---

Part 1: The Experiment (The Mouse Garden)

The scientists used a special type of mouse (CBA females mated with DBA males) that is famous for being a bit "picky" about pregnancy. They surgically created endometriosis-like lesions (the weeds) in these mice.

What happened?

• The Weed Effect: Just like in humans, the mice with the "weeds" had fewer babies. Many of the embryos that did start growing were "resorbed" (the body absorbed them because they couldn't survive), which is the mouse equivalent of a miscarriage.
• The Clue: The scientists looked at the garden at an early stage (when the seed is just sprouting) and found that the soil (the uterine lining) was confused and inflamed.

Part 2: The "Training" (The Immunomodulation)

Here is the clever part. Before creating the "weeds," the scientists gave one group of mice a tiny, harmless dose of a bacterial trigger (LPS) for a few days.

Think of this as teaching the security guards (immune cells) a new rule.

• Normally, the guards see the "weed" and panic, attacking everything and causing chaos (inflammation).
• The "training" (Immunomodulation) taught the guards to be calm and tolerant. Instead of attacking, they learned to stand down and let the garden grow.

The Result:
The mice that got this "training" had much better outcomes.

• The weeds grew smaller.
• More seeds survived.
• Fewer miscarriages occurred.
• The garden looked much more like a healthy, normal garden.

Part 3: The Microscope (Looking at the Soil and Guards)

To understand why the training worked, the scientists used a high-tech microscope (single-cell RNA sequencing) to look at the individual cells in the "garden" at a molecular level. They looked at two main groups: the Soil Cells (Decidual Stromal Cells) and the Security Guards (Immune Cells).

1. The Soil Cells (The Foundation)

In the untrained mice with endometriosis, the soil cells were acting weird:

• The "Gata4" Switch: They had a gene called Gata4 turned up too high. Imagine a volume knob on a radio turned to maximum static. This gene is known to be high in endometriosis patients, and it seems to confuse the soil.
• The "Prap1" Switch: They had a gene called Prap1 turned down too low. This gene is like a "Welcome Mat" for the baby. Without it, the baby doesn't know how to stick to the soil.

The Fix: In the trained mice, the "volume knob" (Gata4) was turned down, and the "Welcome Mat" (Prap1) was put back out. The soil was ready to receive the baby again.

2. The Security Guards (The Immune System)

The scientists also looked at the immune cells (NK cells and Macrophages) living in the garden.

• The Problem: In the untrained mice, the guards were confused.
  • The Macrophages (the cleanup crew) were screaming "Fire!" (inflammation) when there was no fire.
  • The NK Cells (the specialized defenders) stopped listening to a critical signal called Interferon-gamma (IFN-γ).
• Why IFN-γ matters: Think of IFN-γ as the foreman's whistle. It tells the NK cells to remodel the blood vessels so the baby gets enough food. If the guards ignore the whistle, the blood vessels don't change, the baby starves, and the pregnancy fails.
• The Fix: The "training" calmed the Macrophages down and, crucially, re-tuned the NK cells so they could hear the foreman's whistle again.

The Takeaway: A New Way to Help

This study is like finding a new way to fix a broken garden without just pulling out the weeds.

1. Endometriosis doesn't just hurt the womb; it confuses the entire ecosystem (the soil and the immune guards) right from the moment a baby tries to implant.
2. The "Training" worked: By training the immune system before the pregnancy (pre-conception), the scientists were able to partially reverse the damage. They didn't just shrink the weeds; they fixed the soil and re-tuned the guards.
3. Future Hope: This suggests that for women with endometriosis who are struggling to have a baby, we might not just need to treat the pain or the cysts. We might need to calm the immune system first. If we can teach the body's defenses to be "tolerant" before conception, we might be able to prevent miscarriages and help these women grow healthy families.

In short: The paper shows that endometriosis creates a noisy, chaotic environment that scares off a pregnancy. But by "training" the immune system to be calm and tolerant beforehand, we can quiet the noise, fix the soil, and give the baby a fighting chance.

Technical Summary

1. Problem Statement

Endometriosis is a chronic gynecological disease affecting ~10% of reproductive-age women, associated with infertility, higher risks of miscarriage, and obstetric complications (e.g., preeclampsia, placental defects). While clinical data suggests defects in implantation and placentation, the underlying molecular mechanisms remain unclear due to the difficulty of studying early human pregnancy. Specifically, it is unknown how the chronic inflammatory state of endometriosis alters the maternal-fetal interface (MFI) and whether these defects can be mitigated by modulating the immune system prior to conception.

2. Methodology

The study utilized a multi-faceted approach combining a surgically induced mouse model of endometriosis with advanced single-cell genomics.

• Animal Model:

  • Strain: CBA/J females crossed with DBA/2 males (an abortion-prone cross commonly used to study pregnancy immunology).
  • Endometriosis Induction: Syngeneic grafting of uterine horn fragments onto the peritoneal wall of recipient mice.
  • Immunomodulation (IMM): A "trained immunity" approach was used. Mice received daily peritoneal injections of low-dose LPS (0.1 mg/kg) for 5 days before endometriosis induction to induce an anti-inflammatory, immunotolerant phenotype in innate immune cells.
  • Groups: Sham (surgery only), PBS-EDT (Endometriosis + PBS control), and IMM-EDT (Endometriosis + LPS training).
  • Pregnancy Monitoring: Ultrasound imaging tracked implantation sites (E7.5–E10.5) and fetal resorption (E11.5–E14.5). Mice were sacrificed at E18.5 for phenotypic analysis.

• Single-Cell Transcriptomics:

  • Timepoint: E9.5 (early gestation), focusing on the fetal-maternal interface.
  • Techniques:
    • snRNA-seq (Single-nucleus RNA sequencing): Performed on whole placental/decidual tissues to profile all cell types (stromal, trophoblast, endothelial, immune).
    • CITE-seq (Cellular Indexing of Transcriptomes and Epitopes by Sequencing): Performed on isolated CD45+ immune cells to combine surface protein markers (e.g., NKp46, F4/80, CD3) with transcriptomic data for higher resolution immune profiling.
  • Analysis: Data was processed using Seurat (clustering, integration) and Muscat (differential expression). Gene Set Enrichment Analysis (GSEA) was performed using the Hallmark database.

3. Key Contributions

• Validation of a New Model: Successfully recapitulated endometriosis-associated pregnancy complications (reduced implantation, increased resorption) in the CBA/DBA mouse model, validating it for studying gestational immunology.
• Proof of Concept for Preconceptional Therapy: Demonstrated that inducing "trained immunity" via low-dose LPS before endometriosis induction significantly improves pregnancy outcomes.
• Single-Cell Resolution of Mechanisms: Provided the first single-cell transcriptomic map of the E9.5 fetal-maternal interface in endometriosis, identifying specific cell-type-specific dysregulations.
• Identification of Key Drivers: Pinpointed Gata4 upregulation and Prap1 downregulation in decidual stromal cells (DSC) as central molecular defects, and identified a specific failure in IFN$\gamma$ signaling in NK cells as a cause of vascular remodeling defects.

4. Key Results

A. Phenotypic Outcomes

• Endometriosis Impact: The PBS-EDT group showed a 10% decrease in implantation sites and a 2-fold increase in fetal resorption rates (36.9% vs. 18.9% in Sham). Lesion size correlated positively with resorption rates.
• Immunomodulation Efficacy: The IMM-EDT group showed:
  • Significantly smaller endometriosis lesions at sacrifice.
  • A 20% increase in implantation sites compared to PBS-EDT.
  • A reduction in resorption rates (24%) approaching Sham levels (19%).
  • Loss of Correlation: The strong correlation between lesion size and resorption rate seen in the PBS group disappeared in the IMM group, suggesting the benefit is driven by inflammation reduction rather than just lesion size.

B. snRNA-seq Findings (Fetal-Maternal Interface)

• Cellular Composition: Identified 13 clusters, including Decidual Stromal Cells (DSC), Trophoblasts, Endothelial cells, and Immune cells.
• Decidual Stromal Cells (DSC): This cell type showed the most significant transcriptomic alterations.
  • Upregulation: Gata4 (a transcription factor linked to endometriosis in humans) was significantly upregulated in PBS-EDT and normalized in IMM-EDT.
  • Downregulation: Prap1 (a marker of uterine receptivity and successful implantation) was downregulated in PBS-EDT and restored in IMM-EDT.
  • Pathways: Endometriosis suppressed proliferation pathways (Myc, E2F, KRAS) in DSCs; IMM treatment partially reversed this.
• Fetal Cells: Even trophoblasts (fetal origin) showed transcriptomic changes, suggesting potential epigenetic transmission of the inflammatory environment from the oocyte/embryo.

C. CITE-seq Findings (Immune Cells)

• Macrophages: Endometriosis induced a pro-inflammatory signature (upregulation of TNF$\alpha$/NF$\kappa$B pathways). IMM treatment normalized this, reducing inflammation.
• NK Cells (uNK): Endometriosis led to a downregulation of IFN$\gamma$ and IFN$\alpha$ response pathways. Since IFN$\gamma$ is critical for spiral artery remodeling and decidua integrity, this defect likely drives fetal resorption. IMM treatment tended to normalize these pathways.
• B Cells: Showed the highest number of differentially expressed genes, with enrichment in immune response pathways, suggesting a previously underapplicated role for B cells in endometriosis-associated pregnancy loss.

5. Significance and Conclusion

• Mechanistic Insight: The study elucidates that endometriosis disrupts pregnancy not just through physical lesions, but by creating a systemic inflammatory environment that alters the transcriptome of the maternal-fetal interface. Specifically, it impairs the function of decidual stromal cells (reducing receptivity) and NK cells (reducing vascular remodeling capacity).
• Therapeutic Implication: The findings suggest that preconceptional immune modulation (specifically inducing trained immunity) can "reset" the maternal immune system, correcting the molecular defects in the decidua and immune cells, thereby improving implantation and reducing miscarriage risk.
• Future Directions: This supports the potential for clinical trials targeting the immune system (e.g., via trained immunity protocols) to improve pregnancy outcomes in women with endometriosis. It also highlights the need to study epigenetic transmission of endometriosis effects to the next generation.